FATE THERAPEUTICS INC — Director's Dealing 2014

Jun 10, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FATE THERAPEUTICS INC (FATE)
CIK: 0001434316
Period of Report: 2014-06-06

Reporting Person: Nashat Amir (Director, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-06-06	Stock Option (right to buy)	$6.71	A	10000	Acquired	2024-06-05	Common Stock (10000)	Direct

Footnotes

F1: The shares subject to this option shall vest on the earlier of (i) June 6, 2015 or (ii) the date of the 2015 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors.